Euroespes SA
MAD:EEP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Euroespes SA
Net Income
Euroespes SA
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Euroespes SA
MAD:EEP
|
Net Income
-€319.3k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Pangaea Oncology SA
MAD:PANG
|
Net Income
-€1.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Euroespes SA
Glance View
EuroEspes SA engages in the provision of biomedical services. The company is headquartered in Bergondo, La Coruna. The company went IPO on 2012-06-21. The firm operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Company’s medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The firm operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.
See Also
What is Euroespes SA's Net Income?
Net Income
-319.3k
EUR
Based on the financial report for Dec 31, 2024, Euroespes SA's Net Income amounts to -319.3k EUR.
What is Euroespes SA's Net Income growth rate?
Net Income CAGR 5Y
20%
Over the last year, the Net Income growth was 85%. The average annual Net Income growth rates for Euroespes SA have been -22% over the past three years , 20% over the past five years .
